These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 30296701)

  • 1. Fenofibrate improves vascular endothelial function and contractility in diabetic mice.
    Xu N; Wang Q; Jiang S; Wang Q; Hu W; Zhou S; Zhao L; Xie L; Chen J; Wellstein A; Lai EY
    Redox Biol; 2019 Jan; 20():87-97. PubMed ID: 30296701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fenofibrate improves vascular endothelial function in diabetic mice.
    Xin R; An D; Li Y; Fu J; Huang F; Zhu Q
    Biomed Pharmacother; 2019 Apr; 112():108722. PubMed ID: 30970521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term fenofibrate treatment impairs endothelium-dependent dilation to acetylcholine by altering the cyclooxygenase pathway.
    Blanco-Rivero J; Márquez-Rodas I; Xavier FE; Aras-López R; Arroyo-Villa I; Ferrer M; Balfagón G
    Cardiovasc Res; 2007 Jul; 75(2):398-407. PubMed ID: 17412316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fenofibrate improves age-related endothelial dysfunction in rat resistance arteries.
    Alvarez de Sotomayor M; Mingorance C; Andriantsitohaina R
    Atherosclerosis; 2007 Jul; 193(1):112-20. PubMed ID: 16979646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renoprotective Effects of Fenofibrate via Modulation of LKB1/AMPK mRNA Expression and Endothelial Dysfunction in a Rat Model of Diabetic Nephropathy.
    Al-Rasheed NM; Al-Rasheed NM; Attia HA; Al-Amin MA; Al-Ajmi HN; Hasan IH; Mohamad RA; Sinjilawi NA
    Pharmacology; 2015; 95(5-6):229-39. PubMed ID: 25967095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fenofibrate improves vascular endothelial function by reducing oxidative stress while increasing endothelial nitric oxide synthase in healthy normolipidemic older adults.
    Walker AE; Kaplon RE; Lucking SM; Russell-Nowlan MJ; Eckel RH; Seals DR
    Hypertension; 2012 Dec; 60(6):1517-23. PubMed ID: 23108655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fenofibrate Ameliorates Oxidative Stress-Induced Retinal Microvascular Dysfunction in Diabetic Rats.
    Li J; Wang P; Chen Z; Yu S; Xu H
    Curr Eye Res; 2018 Nov; 43(11):1395-1403. PubMed ID: 30024319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vascular endothelium as a target of beraprost sodium and fenofibrate for antiatherosclerotic therapy in type 2 diabetes mellitus.
    Otsuki M; Goya K; Kasayama S
    Vasc Health Risk Manag; 2005; 1(3):209-15. PubMed ID: 17319106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fenofibrate decreases asymmetric dimethylarginine level in cultured endothelial cells by inhibiting NF-kappaB activity.
    Yang TL; Chen MF; Luo BL; Xie QY; Jiang JL; Li YJ
    Naunyn Schmiedebergs Arch Pharmacol; 2005 May; 371(5):401-7. PubMed ID: 15915325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fenofibrate treatment enhances antioxidant status and attenuates endothelial dysfunction in streptozotocin-induced diabetic rats.
    Olukman M; Sezer ED; Ulker S; Sözmen EY; Cınar GM
    Exp Diabetes Res; 2010; 2010():828531. PubMed ID: 21234421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pioglitazone, a PPARgamma agonist, restores endothelial function in aorta of streptozotocin-induced diabetic rats.
    Majithiya JB; Paramar AN; Balaraman R
    Cardiovasc Res; 2005 Apr; 66(1):150-61. PubMed ID: 15769458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The peroxisome proliferator-activated receptor α agonist fenofibrate decreases airway reactivity to methacholine and increases endothelial nitric oxide synthase phosphorylation in mouse lung.
    Becker J; Delayre-Orthez C; Frossard N; Pons F
    Fundam Clin Pharmacol; 2012 Jun; 26(3):340-6. PubMed ID: 21392098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The interleukin-1 receptor antagonist anakinra improves endothelial dysfunction in streptozotocin-induced diabetic rats.
    Vallejo S; Palacios E; Romacho T; Villalobos L; Peiró C; Sánchez-Ferrer CF
    Cardiovasc Diabetol; 2014 Dec; 13():158. PubMed ID: 25518980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of glucagon-like peptide-1 on advanced glycation endproduct-induced aortic endothelial dysfunction in streptozotocin-induced diabetic rats: possible roles of Rho kinase- and AMP kinase-mediated nuclear factor κB signaling pathways.
    Tang ST; Zhang Q; Tang HQ; Wang CJ; Su H; Zhou Q; Wei W; Zhu HQ; Wang Y
    Endocrine; 2016 Jul; 53(1):107-16. PubMed ID: 26758998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Saxagliptin prevents vascular remodeling and oxidative stress in db/db mice. Role of endothelial nitric oxide synthase uncoupling and cyclooxygenase.
    Solini A; Rossi C; Duranti E; Taddei S; Natali A; Virdis A
    Vascul Pharmacol; 2016 Jan; 76():62-71. PubMed ID: 26455387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PPAR-alpha activator fenofibrate increases renal CYP-derived eicosanoid synthesis and improves endothelial dilator function in obese Zucker rats.
    Zhao X; Quigley JE; Yuan J; Wang MH; Zhou Y; Imig JD
    Am J Physiol Heart Circ Physiol; 2006 Jun; 290(6):H2187-95. PubMed ID: 16501022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of 3,4-dihydroxyacetophenone on endothelial dysfunction in streptozotocin-induced rats with type 2 diabetes.
    Liu C; Sun J; Xue F; Yi Y; Han A
    J Cardiovasc Pharmacol; 2015 Jan; 65(1):22-7. PubMed ID: 25162436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination therapy with losartan and L-carnitine protects against endothelial dysfunction of streptozotocin-induced diabetic rats.
    Sleem M; Taye A; El-Moselhy MA; Mangoura SA
    Eur J Pharmacol; 2014 Dec; 744():10-7. PubMed ID: 25281836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fenofibrate attenuates nicotine-induced vascular endothelial dysfunction in the rat.
    Chakkarwar VA
    Vascul Pharmacol; 2011; 55(5-6):163-8. PubMed ID: 21864717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced nitric oxide-mediated relaxation and endothelial nitric oxide synthase expression in the tail arteries of streptozotocin-induced diabetic rats.
    Mokhtar SS; Vanhoutte PM; Leung SW; Suppian R; Yusof MI; Rasool AH
    Eur J Pharmacol; 2016 Feb; 773():78-84. PubMed ID: 26825543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.